Spironolactone and Testicular Cytochrome P-450: Decreased Testosterone Formation inSeveral Species and Changes in Hepatic Drug Metabolism1
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The daily administration of spironolactone caused a 40–90% decrease in the level of microsomal cytochrome P-450 in the testes of rat, guinea pig, rabbit, mouse and dog, but no reduction was detected in the amount of cytochrome b5. The loss of microsomal cytochrome P-450 was concomitant with a similar loss of both the microsomal heme associated with cytochrome P-450 and the activity of the microsomal 17α-hydroxylase. In contrast to its effects on the 17α-hydroxylase, spironolactone administration slightly increased the enzyme activity of the microsomal 17β-dehydrogenase. The extent of the destruction of cytochrome P-450 by spironolactone was dependent upon the dosegiven and upon the duration of the treatment. The decline in androgen formation in the testis resulted in a 30–35% decrease in the activity ofhepatic 3,4-benzpyrene hydroxylase in the rat, but an 80% increase in the guinea pig. The decrease inthe 3,4-benzpyrene hydroxylase activity in the rat could be prevented by the administration ofandrogens, such as 17-methyltestosterone. In contrast to the decline in 3,4-benzpyrene hydroxylaseactivity in the male rat, spironolactone administration enhanced the activity of both ethylmorphine N-demethylase and NADPH cytochrome c reductase in the liver of the male rat and guinea pig. Other steroids such as progesterone and testosterone, given at a dose similar to that of spironolactone, also lowered the content of cytochrome P-450 in the testis. However, in contrast to the rapid destruction of cytochrome P-450 by spironolactone, the decrease in the level ofcytochrome P-450 bytestosterone or progesterone is probably caused by a decline in the level of LHresulting from asteroidfeedback inhibition on the release of LH from the pituitary gland. (Endocrinology94: 1628, 1974)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Spironolactone is an aldosterone receptor antagonist that decreases testosterone production and competitively inhibits testosterone and dihydrotestosterone binding to androgen receptors in the skin.”
From Guidelines of care for the management of acne vulgaris (2024) · cites this paper as [227]
Citations
Cites
Porphyrins and Metalloporphyrins
(1978) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(00)80351-3 · Cited by 1,716
Hormones and Resistance: Part 1 and Part 2
Selye, H. (1971) · Springer eBooks · doi:10.1007/978-3-642-65192-2 · Cited by 220
Cited by
Guidelines of care for the management of acne vulgaris
Zaenglein, A. L., Pathy, A. L., Schlosser, B. J., Alikhan, A., Baldwin, H. E., Berson, D. S., Bowe, W. P., Graber, E. M., Harper, J. C., Kang, S., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.12.037 · Cited by 1,597
Guidelines of care for the management of acne vulgaris
Reynolds, R. V., Yeung, H., Cheng, C. E., Cook-Bolden, F., Desai, S. R., Druby, K. M., Freeman, E. E., Keri, J. E., Stein Gold, L. F., Tan, J. K. L., et al. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.12.017 · Cited by 518
Cigorraga, S. B., Dufau, M. L., & Catt, K. J. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34719-1 · Cited by 206
Pathophysiology of Spironolactone-Induced Gynecomastia
ROSE, L. I., UNDERWOOD, R. H., NEWMARK, S. R., KISCH, E. S., & WILLIAMS, G. H. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-4-398 · Cited by 193
Spironolactone and Endocrine Dysfunction
LORIAUX, D. L., MENARD, R., TAYLOR, A., PITA, J. C., & SANTEN, R. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-5-630 · Cited by 170
Self-citation
Metadata
- Authors
- MENARD, R. H., STRIPP, B., & GILLETTE, J. R.
- Affiliations
- National Institutes of Health (US)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1974-06
- Volume
- 94
- Issue
- 6
- Pages
- 1628-1636
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W1981955326
- Cited by
- 117
- References
- 2
- Citations by year
- 2025: 1 · 2024: 2 · 2022: 2 · 2021: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- spironolactone, testosterone production, 17α-hydroxylase, cytochrome b5, hepatic drug metabolism, ethylmorphine N-demethylase, NADPH-cytochrome c reductase, progesterone, testosterone, species differences
- MeSH terms
- Animals, Carbon Radioisotopes, Cytochrome P-450 Enzyme System, Cytochromes, Dogs, Female, Guinea Pigs, Heme, Liver, Male, Methyltestosterone, Microsomes, Pregnenolone, Progesterone, Rabbits, Spironolactone, Steroid Hydroxylases, Testis, Testosterone, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Spironolactone and Testicular Cytochrome P-450: Decreased Testosterone Formation inSeveral Species and Changes in Hepatic Drug Metabolism1. https://app.cochat.ai/papers/10.1210/endo-94-6-1628
- The paper
- MENARD, R. H., STRIPP, B., & GILLETTE, J. R. (1974). Spironolactone and Testicular Cytochrome P-450: Decreased Testosterone Formation inSeveral Species and Changes in Hepatic Drug Metabolism1. Endocrinology. https://doi.org/10.1210/endo-94-6-1628
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.